Ryo Saito

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Atopic Dermatitis

Vascular Endothelial Growth Factor

Top Venues

The Journal of dermatology

Dermatologic therapy

The Australasian journal of dermatology

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Ryo Saito, Qianru Mu, Yu Yuan, Marcos Rubio-Alarcón, Maria Eznarriaga, Pingwei Zhao, Gihan Gunaratne, Sushil Kumar, Marco Keller, Franz Bracher, Christian M Grimm, Eugen Brailoiu, Jonathan S Marchant, Taufiq Rahman, Sandip Patel
Convergent activation of Ca 2+ permeability in two-pore channel 2 through distinct molecular routes. Science signaling 16 (799) (2023)
Ryo Saito, Shunsuke Takahagi, Fumi Nakano, Kiyoshi Furutani, Shoji Mihara, Tsunemi Numata, Yoshikazu Kameyoshi, Toshihiko Tanaka, Hajime Shindo, Naomasa Niimi, Kazumasa Iwamoto, Takaaki Hiragun, Makiko Hiragun, Akio Tanaka, Michihiro Hide
A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan. The Journal of dermatology 49 (12) (2022)
Takako Ishida, Ryo Saito, Shunsuke Takahagi, Akio Tanaka
Case of presenile diffuse sebaceous hyperplasia treated with adapalene gel. The Journal of dermatology 49 (7) (2022)
Masataka Suehiro, Tomofumi Numata, Emi Murakami, Masakazu Takahashi, Ryo Saito, Satoshi Morioke, Akiko Kamegashira, Shunsuke Takahagi, Michihiro Hide, Akio Tanaka
Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis. Dermatologic therapy 35 (7) (2022)
Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Masakazu Takahashi, Maiko Tanaka, Shunsuke Takahagi, Takanobu Kan, Kazumasa Iwamoto, Ryo Saito, Michihiro Hide
Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan. The Journal of dermatology 48 (10) (2021)
Akio Tanaka, Satoshi Morioke, Yukihiro Ohya, Naoki Shimojo, Ashizawa Shinichi, Hiroko Shizukawa, Shunsuke Takahagi, Takanobu Kan, Ryo Saito, Michihiro Hide
Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood. The Journal of dermatology 48 (5) (2021)
Daiki Matsubara, Shunsuke Takahagi, Ryo Saito, Akiko Kamegashira, Akio Tanaka, Michihiro Hide
Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria. The Journal of dermatology 48 (1) (2020)
Ryo Saito, Akio Tanaka, Shunsuke Takahagi, Maiko Tanaka, Michihiro Hide
Pemphigus foliaceus with inconsistent findings between clinical features and titres of antidesmoglein autoantibodies. The Australasian journal of dermatology 62 (1) (2020)
Akiko Kamegashira, Yuhki Yanase, Shunsuke Takahagi, Ryo Saito, Kazue Uchida, Tomoko Kawaguchi, Kaori Ishii, Akio Tanaka, Koichiro Ozawa, Michihiro Hide
Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1β. The Journal of dermatology 47 (11) (2020)
Ryo Saito, Yuhki Yanase, Akiko Kamegashira, Shunsuke Takahagi, Akio Tanaka, Kazue Uchida, Tomoko Kawaguchi, Michihiro Hide
Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria. Allergy 75 (4) (2019)
Ryo Saito, Akio Tanaka, Takaaki Hiragun, Kazumasa Iwamoto, Shunsuke Takahagi, Masakazu Takahashi, Michihiro Hide
Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis. The Journal of dermatology 46 (12) (2019)
Ryo Saito, Kazumasa Iwamoto, Yurie Tanaka, Mikio Kawai, Michihiro Hide
Rapid exacerbation of malignant melanoma during short-term discontinuation of vemurafenib. The Australasian journal of dermatology 59 (4) (2018)
Ryo Saito, Mikio Kawai, Kayoko Hirakawa, Maiko Tanaka, Shunsuke Takahagi, Michihiro Hide
Case of malignant melanoma responding to dacarbazine following nivolumab. Dermatologic therapy 32 (2) (2018)